Genmab A-S (GMAB) had the highest return between 2013 and 2015 by a large-cap US stock, returning 857.3%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Genmab A-S (GMAB) | 2013-2015 | 857.29% |
Netflix (NFLX) | 2013-2015 | 740.97% |
Neurocrine Biosciences (NBIX) | 2013-2015 | 636.59% |
Celsius (CELH) | 2013-2015 | 593.14% |
Tesla (TSLA) | 2013-2015 | 585.75% |
Incyte (INCY) | 2013-2015 | 548.62% |
DexCom (DXCM) | 2013-2015 | 489.63% |
Ionis Pharmaceuticals (IONS) | 2013-2015 | 482.6% |
Alnylam Pharmaceuticals (ALNY) | 2013-2015 | 396.78% |
Broadcom (AVGO) | 2013-2015 | 370.19% |
Electronic Arts (EA) | 2013-2015 | 365.27% |
NetEase (NTES) | 2013-2015 | 345.99% |
Delta Air Lines (DAL) | 2013-2015 | 329.69% |
Southwest Airlines (LUV) | 2013-2015 | 321.59% |
Constellation Brands Inc Class A (STZ) | 2013-2015 | 299.2% |
Trip Group Ltd ADR (TCOM) | 2013-2015 | 294.3% |
Facebook (META) | 2013-2015 | 281.41% |
Tyler Technologies (TYL) | 2013-2015 | 252.87% |
Dycom Industries (DY) | 2013-2015 | 248.23% |
Diamondback Energy (FANG) | 2013-2015 | 243.78% |
Illumina (ILMN) | 2013-2015 | 242.16% |
Kroger (KR) | 2013-2015 | 231.48% |
Palo Alto Networks (PANW) | 2013-2015 | 223.08% |
Centene (CNC) | 2013-2015 | 214.73% |
Boston Scientific (BSX) | 2013-2015 | 214.68% |
Large-cap stocks are treated as having a market cap of $10B+.
